The AdvaMed medical conference witnessed extensive discussions on medical technology companies reshaping their supply chain strategies amidst escalating geopolitical risks and tariff fluctuations, alongside the ongoing semiconductor crisis that coincides with the massive expansion of artificial intelligence data center infrastructure.
Fierce Competition for Chips with the AI Sector
Jon Reinert, Chairman of Zoll Medical, explained that the medical device industry is facing a new crisis in semiconductor supplies, as medical device companies compete with the massive demand from artificial intelligence data centers for the same essential electronic components used in critical care devices and automated external defibrillators.
Reinert pointed out that the just-in-time inventory strategy has become unviable in the healthcare sector, prompting his company to inject massive investments into increasing buffer inventory to buy the necessary time to face any sudden changes, in addition to building direct relationships with chip manufacturers rather than relying entirely on contract component makers.
Risk Management and Prioritizing Life-Saving Products
For her part, Heather Knight, Chief Commercial Officer of Solventum—the company spun off from 3M—affirmed that continuous scenario planning is imperative to deal with supply chain disruptions resulting from weather conditions, cyberattacks, or sudden halts in component production. Because the company manages more than 30,000 stock-keeping units (SKUs), building a surplus for every product portfolio is unfeasible, which requires giving top priority to life-saving products and building resilience starting with those products.
In the same context, Christopher Toth, CEO of Vantive, emphasized the necessity of adopting integrated disaster recovery plans and appointing regional executives who bear direct financial responsibility for inventory levels to ensure the continuous delivery of home dialysis solutions to patients without interruption.
What is Practically Changing in the Medical Technology Sector?
Major medical technology companies are moving toward applying the principle of local purchasing and manufacturing in target markets to reduce complex global shipping operations, and working on pre-registering products with regulatory authorities in various regions to shorten lead times during crises. Companies are also forced to redouble their efforts in developing alternative supply channels capable of providing immediate production capacities when traditional factories halt due to economic or tariff pressures.